[1] [1] SIEGEL R L, WAGLE N S, CERCEK A, et al. Colorectal cancer statistics, 2023[J]. CA A Cancer J Clin, 2023, 73(3): 233-254.

[2] [2] KELLER D S, BERHO M, PEREZ R O, et al. The multidisciplinary management of rectal cancer[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(7): 414-429.

[3] [3] SAUER R, LIERSCH T, MERKEL S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase Ⅲ trial after a median follow-up of 11 years[J]. J Clin Oncol, 2012, 30(16): 1926-1933.

[4] [4] BODY A, PRENEN H, LAM M, et al. Neoadjuvant therapy for locally advanced rectal cancer: recent advances and ongoing challenges[J]. Clin Colorectal Cancer, 2021, 20(1): 29-41.

[5] [5] VAN DER VALK M J M, HILLING D E, BASTIAANNET E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study[J]. Lancet, 2018, 391(10139): 2537-2545.

[6] [6] GARCIA-AGUILAR J, PATIL S, GOLLUB M J, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy[J]. J Clin Oncol, 2022, 40(23): 2546-2556.

[7] [7] VERHEIJ F S, OMER D M, WILLIAMS H, et al. Longterm results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase Ⅱ OPRA trial[J]. J Clin Oncol, 2024, 42(5): 500-506.

[8] [8] THOMPSON H M, OMER D M, LIN S, et al. Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial[J]. JAMA Netw Open, 2024, 7(1): e2350903.

[9] [9] ASNONG A, D'HOORE A, VAN KAMPEN M, et al. The role of pelvic floor muscle training on low anterior resection syndrome: a multicenter randomized controlled trial[J]. Ann Surg, 2022, 276(5): 761-768.

[10] [10] CERCEK A, FOOTE M B, ROUSSEAU B, et al. Nonoperative management of mismatch repair-deficient tumors[J]. N Engl J Med, 2025, 392(23): 2297-2308.

[11] [11] LI Y J, PAN C H, GAO Y Y, et al. Total neoadjuvant therapy with PD-1 blockade for high-risk proficient mismatch repair rectal cancer[J]. JAMA Surg, 2024, 159(5): 529-537.

[12] [12] LIN Z Y, ZHANG P, CHI P, et al. Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase Ⅲ trial[J]. Ann Oncol, 2024, 35(10): 882-891.

[13] [13] YANG Y C, PANG K, LIN G L, et al. Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial[J]. Nat Med, 2025, 31(2): 449-456.

[14] [14] XIA F, WANG Y Q, WANG H, et al. Randomized phase Ⅱ trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (TORCH)[J]. J Clin Oncol, 2024, 42(28): 3308-3318.

[15] [15] GERARD J P, BARBET N, SCHIAPPA R, et al. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact X-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2023, 8(4): 356-367.

[16] [16] XIA F, CHEN Y, WANG Y, et al. Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in proficient mismatch repair or microsatellite stable (pMMR/MSS) low-lying early rectal cancer: preliminary findings from a prospective, multi-center, phase Ⅱ trial (TORCH-E)[J]. Ann Oncol, 2024, 35: S462.

[17] [17] LI X X, LIANG L, SHI D B, et al. Vessel-centered laparoscopic total mesorectal excisionviamedial approach[J]. Transl Cancer Res, 2018, 7(3): 744-757.

[20] [20] CASSINOTTI E, AL-TAHER M, ANTONIOU S A, et al. European Association for Endoscopic Surgery (EAES) consensus on indocyanine green (ICG) fluorescence-guided surgery[J]. Surg Endosc, 2023, 37(3): 1629-1648.

[22] [22] ZHUO C H, LIANG L, YING M G, et al. Laparoscopic low anterior resection and eversion technique combined with a nondog ear anastomosis for mid- and distal rectal neoplasms: a preliminary and feasibility study[J]. Medicine (Baltimore), 2015, 94(50): e2285.